AI Summary
Lecanemab may block a molecular cascade linked to amyloidosis in Alzheimer's disease (AD), according to a study.
How does lecanemab work in AD? A study suggests it blocks the action of a molecular cascade implicated in amyloidosis.
Medscape Medical News